Drug firm GlaxoSmithKline Pharmaceuticals has decided to concentrate on 20 key brands to drive growth going forward. In keeping with their global approach on focusing energy...
Jubilant Life Sciences has earmarked Rs 550 crore for capital expenditure (CapEx) in the current financial year. It is also planning to invest Rs 300 crore in research...
Zydus Cadila has received the final approval from the US FDA to market Gemfibrozil tablets USP 600 mg (US RLD – Lopid), and Aripiprazole orally disintegrating...
Pharmaceutical giant, Lupin Limited expects to train more than 1000 undergraduates to become pharma professionals by the year 2020 under its Learn and Earn initiative. Lupin...
Novartis has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo...
Sun Pharmaceutical Industries Ltd. has launched Kapspargo Sprinkle (metoprolol succinate) extended-release capsules in the United States of America, for the treatment of hypertension (to lower blood...
Pharma major Lupin Limited reported its financial performance for the first quarter ending June 30, 2018. Sales for the quarter were Rs. 37,746 million compared to Rs. 39,785...
Dr. Reddy’s Laboratories Ltd. has launched Hervycta (Trastuzumab), a biosimilar of Roche’s Herceptin in India, indicated for the treatment of HER2-positive cancers (early breast cancer, metastatic...
Cipla USA, Inc., a subsidiary of Cipla Limited, has secured rights from MSN Laboratories Private Limited to market and distribute Capecitabine 150 mg and 500 mg...
Zydus Cadila has received the final approval from the USFDA to market azithromycin for oral suspension USP (US RLD – Zithromax), 100 mg/5 mL and 200...
Glenmark Pharmaceuticals Ltd has entered into a collaboration with leading, home-grown private equity firm True North for its orthopedic and pain management business for markets in...
Sanofi Pasteur, the vaccine division of Sanofi, announced the launch of its four-strain influenza vaccine FluQuadri in India. FluQuadri will be India’s first quadrivalent vaccine to...
Alembic Pharmaceuticals has received tentative approval from the USFDA for its abbreviated new drug application (ANDA) for Bimatoprost ophthalmic solution, 0.03 percent. The tentatively approved ANDA...
Granules India Ltd., announced financial results for its fourth quarter and financial year ended on March 31, 2018. The company’s standalone total income during the year was...
Strides Shasun has sought shareholders’ nod to change its name to Strides Pharma Science. This is the second time in 3 years, when the name of...
Copyright © 2024 Medical Buyer